Signaturefd LLC Buys New Stake in Bovie Medical Co. (BVX)

Signaturefd LLC purchased a new stake in Bovie Medical Co. (NYSEAMERICAN:BVX) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 31,350 shares of the medical device company’s stock, valued at approximately $136,000. Signaturefd LLC owned about 0.09% of Bovie Medical at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. BlackRock Inc. lifted its position in Bovie Medical by 17.7% in the second quarter. BlackRock Inc. now owns 106,961 shares of the medical device company’s stock valued at $465,000 after acquiring an additional 16,115 shares during the last quarter. Royce & Associates LP lifted its position in Bovie Medical by 3.4% in the second quarter. Royce & Associates LP now owns 710,000 shares of the medical device company’s stock valued at $3,088,000 after acquiring an additional 23,400 shares during the last quarter. Cowen Prime Services LLC lifted its position in Bovie Medical by 10.3% in the second quarter. Cowen Prime Services LLC now owns 348,093 shares of the medical device company’s stock valued at $1,514,000 after acquiring an additional 32,636 shares during the last quarter. Cortina Asset Management LLC lifted its position in Bovie Medical by 5.4% in the second quarter. Cortina Asset Management LLC now owns 658,528 shares of the medical device company’s stock valued at $2,865,000 after acquiring an additional 33,992 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its position in Bovie Medical by 46.3% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 147,350 shares of the medical device company’s stock valued at $641,000 after acquiring an additional 46,600 shares during the last quarter.

Shares of NYSEAMERICAN:BVX opened at $6.06 on Tuesday. Bovie Medical Co. has a one year low of $2.28 and a one year high of $7.62.

Bovie Medical (NYSEAMERICAN:BVX) last issued its quarterly earnings results on Wednesday, August 1st. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). Bovie Medical had a negative net margin of 13.32% and a negative return on equity of 21.67%. The business had revenue of $11.50 million for the quarter, compared to analyst estimates of $11.38 million. The firm’s revenue for the quarter was up 17.3% on a year-over-year basis.

A number of brokerages have recently commented on BVX. Dougherty & Co began coverage on shares of Bovie Medical in a report on Friday, September 14th. They issued a “buy” rating and a $11.00 target price for the company. JMP Securities upped their target price on shares of Bovie Medical from $6.00 to $8.50 and gave the company a “market outperform” rating in a report on Thursday, September 6th. Two equities research analysts have rated the stock with a sell rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $9.75.

Bovie Medical Company Profile

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue.

Further Reading: What does the Dow Jones Industrial Average (DJIA) measure?

Institutional Ownership by Quarter for Bovie Medical (NYSEAMERICAN:BVX)

Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply